Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

NervGen Pharma: Proof that NVG-291 works?

It’s arguably a Eureka moment for investors in NervGen Pharma (TSX.V: NGEN) (OTCQB: NGENF). Tantalizing anecdotal “evidence” has just been published that suggests that NervGen’s prospective wonder-drug — NVG-29...
Knox Henderson | 5 days ago |

Brianne Gardner's 2025 stock picks

As you will see in the full video above, Brianne Gardner , senior wealth manager at Velocity Investments, Raymond James Canada reviews her past picks from September to see if they are on the money and she gives three new diversified picks for 2025 in healthcare, ener...
Coreena Robertson | 9 days ago |

A potential breakthrough in spinal cord and optic nerve injury treatment

Click Here to Download the Full Report This is third-party provided content issued on behalf of NurExone Biologic Inc., please see full disclaimer here .
Research | 9 days ago |

Can you get profit and purpose in business?

In the above video we have a conversation with Aleks Paunovic, co-owner of newly launched Legend Water , a company on a mission for profits and purpose. As well, to diversify your portfolio, check out three TSX water companies that are significantly up on the...
Coreena Robertson | 11 days ago |

In conversation with: Pierre Gratton: How can we built more mines faster in Canada?

The Mining Association of Canada’s President and CEO Pierre Gratton discusses his Vancouver Board of Trade presentation addressing the question, “How can we build more mines faster? He covers several key issues including, the need for critical miner...
Coreena Robertson | December 12, 2024 |

BoC’s Double Rate Cut: Is it a benefit for Canadians

The Bank of Canada (BoC) has implemented a 50-basis-point interest rate cut. This is in responds to a weakening labor market and a 5-year bond yield drop to 2.8%. With unemployment at 6.8%—its highest since 2017 (excluding pandemic years)—the move aims to stimulate the ec...
Lyndsay Malchuk | December 11, 2024 |

NurExone Biologic announces important test results

By Brad Sorensen, CFA, Zacks Research. NurExone Biologic (TSXV:NRX; OTCQB:NRXBF) is developing a product known as ExoPTEN that is designed to treat patients with acute spinal cord injuries, while also conducting preclinical tests for other conditions that ExoPTEN m...
Research | December 11, 2024 |

New research report on Nextech3D.AI by H.C. Wainwright & Co.

Click here for the full report . This is sponsored content issued on behalf of Nextech3D.AI Corp., please see full disclaimer here .
Research | December 10, 2024 |

Lithium and copper demand set to grow in 2025

Lithium has already seen a rise in price since the U.S. presidential election and analysts predict a huge demand for copper . Grid Battery Metals (TSXV:CELL) has lithium projects in Nevada and a Copper in British Columbia and the company’s CEO, Tim Fer...
Research | December 6, 2024 |

Lode Gold: A compelling investment opportunity for gold enthusiasts

Lode Gold (TSXV:LOD) has had a year of growth achieving one milestone after another. Despite facing a challenging market, the company has successfully raised $6M since March 2024. Now, investors have the chance to capitalize on a unique opportunity by investing in Lode ...
Research | December 4, 2024 |
1 2 3 4 5 6 7 8 9 10 ...